CBFP
Cedar Brook Financial Partners’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,770
| Closed | -$216K | – | 9 |
|
|
2024
Q2 | $216K | Sell |
2,770
-9,646
| -78% | -$752K | 1.63% | 23 |
|
|
2024
Q1 | $841K | Sell |
12,416
-56
| -0.4% | -$3.79K | 0.17% | 144 |
|
|
2023
Q4 | $863K | Sell |
12,472
-629
| -5% | -$43.5K | 0.19% | 126 |
|
|
2023
Q3 | $887K | Buy |
13,101
+96
| +0.7% | +$6.5K | 0.23% | 104 |
|
|
2023
Q2 | $931K | Sell |
13,005
-597
| -4% | -$42.7K | 0.22% | 110 |
|
|
2023
Q1 | $944K | Buy |
13,602
+353
| +3% | +$24.5K | 0.24% | 104 |
|
|
2022
Q4 | $898K | Buy |
13,249
+1,258
| +10% | +$85.3K | 0.25% | 108 |
|
|
2022
Q3 | $658K | Buy |
11,991
+1,031
| +9% | +$56.5K | 0.21% | 123 |
|
|
2022
Q2 | $724K | Sell |
10,960
-562
| -5% | -$37.1K | 0.23% | 112 |
|
|
2022
Q1 | $764K | Buy |
11,522
+309
| +3% | +$20.5K | 0.2% | 130 |
|
|
2021
Q4 | $653K | Buy |
11,213
+346
| +3% | +$20.2K | 0.17% | 147 |
|
|
2021
Q3 | $653K | Buy |
10,867
+670
| +7% | +$40.3K | 0.2% | 127 |
|
|
2021
Q2 | $611K | Buy |
10,197
+796
| +8% | +$47.7K | 0.18% | 145 |
|
|
2021
Q1 | $467K | Buy |
9,401
+1,212
| +15% | +$60.2K | 0.16% | 151 |
|
|
2020
Q4 | $409K | Buy |
8,189
+1,034
| +14% | +$51.6K | 0.14% | 168 |
|
|
2020
Q3 | $392K | Buy |
7,155
+112
| +2% | +$6.14K | 0.15% | 168 |
|
|
2020
Q2 | $373K | Sell |
7,043
-145
| -2% | -$7.68K | 0.17% | 162 |
|
|
2020
Q1 | $321K | Sell |
7,188
-436
| -6% | -$19.5K | 0.18% | 161 |
|
|
2019
Q4 | $380K | Sell |
7,624
-162
| -2% | -$8.08K | 0.16% | 171 |
|
|
2019
Q3 | $347K | Buy |
7,786
+870
| +13% | +$38.8K | 0.15% | 189 |
|
|
2019
Q2 | $285K | Buy |
6,916
+258
| +4% | +$10.6K | 0.13% | 214 |
|
|
2019
Q1 | $269K | Buy |
+6,658
| New | +$269K | 0.13% | 214 |
|